现代肿瘤医学
現代腫瘤醫學
현대종류의학
JOURNAL OF MODERN ONCOLOGY
2015年
13期
1783-1786
,共4页
惠晓丽%刘惊涛%刘洋%殷继鹏%方如塘%李明%吴开春
惠曉麗%劉驚濤%劉洋%慇繼鵬%方如塘%李明%吳開春
혜효려%류량도%류양%은계붕%방여당%리명%오개춘
肿瘤%血管靶向%结肠癌%肺癌%GX1
腫瘤%血管靶嚮%結腸癌%肺癌%GX1
종류%혈관파향%결장암%폐암%GX1
tumor%vasculature targeting%colon cancer%lung cancer%GX1
目的:分析肿瘤血管内皮特异性靶向肽GX1在结肠癌与肺癌中的显像差异,探讨GX1在胃肠道肿瘤早期诊治的应用价值。方法:构建荷人结肠癌、肺癌移植瘤裸鼠模型,99 Tcm 直接法制备99 Tcm -GX1,经尾静脉分别注入荷人结肠癌、肺癌小鼠体内,SPECT显像连续追踪24h,观察99 Tcm -GX1在结肠癌与肺癌中显像差异,计算机勾划肿瘤及心脏感兴趣区,比较两组T/NT比值差异。结果:99 Tcm 直接法标记GX1,所得标记率在90%以上,无需纯化,比活度大于200Ci/mmol,满足显像要求。结肠癌组荷瘤小鼠自8h起右后肢背侧肿瘤部位即可见放射性浓聚,并高于心血池本底,T/NT比值>1,18h显影最清晰,随时间延长T/NT比值总体呈递增趋势;肺癌组荷瘤小鼠8h右后肢背侧肿瘤部位无明显显影,自12h起肿瘤部位开始出现放射性浓聚,并高于心血池本底,18h显影最清晰,T/NT比值随时间延长亦呈递增趋势。比较两组T/NT比值,自8h至24h,结肠癌组比值持续高于肺癌组。结论:GX1可靶向到结肠癌与肺癌荷瘤小鼠的肿瘤组织,并具有肿瘤标志物的影像学特征,与肺癌相比,GX1在结肠癌成像中具有更高的灵敏度、更高的体内肿瘤组织滞留率和更高的T/NT比率。结合早期胃癌中研究结果,GX1在胃肠道肿瘤早期时相探测方面较肺癌具有更多优势。
目的:分析腫瘤血管內皮特異性靶嚮肽GX1在結腸癌與肺癌中的顯像差異,探討GX1在胃腸道腫瘤早期診治的應用價值。方法:構建荷人結腸癌、肺癌移植瘤裸鼠模型,99 Tcm 直接法製備99 Tcm -GX1,經尾靜脈分彆註入荷人結腸癌、肺癌小鼠體內,SPECT顯像連續追蹤24h,觀察99 Tcm -GX1在結腸癌與肺癌中顯像差異,計算機勾劃腫瘤及心髒感興趣區,比較兩組T/NT比值差異。結果:99 Tcm 直接法標記GX1,所得標記率在90%以上,無需純化,比活度大于200Ci/mmol,滿足顯像要求。結腸癌組荷瘤小鼠自8h起右後肢揹側腫瘤部位即可見放射性濃聚,併高于心血池本底,T/NT比值>1,18h顯影最清晰,隨時間延長T/NT比值總體呈遞增趨勢;肺癌組荷瘤小鼠8h右後肢揹側腫瘤部位無明顯顯影,自12h起腫瘤部位開始齣現放射性濃聚,併高于心血池本底,18h顯影最清晰,T/NT比值隨時間延長亦呈遞增趨勢。比較兩組T/NT比值,自8h至24h,結腸癌組比值持續高于肺癌組。結論:GX1可靶嚮到結腸癌與肺癌荷瘤小鼠的腫瘤組織,併具有腫瘤標誌物的影像學特徵,與肺癌相比,GX1在結腸癌成像中具有更高的靈敏度、更高的體內腫瘤組織滯留率和更高的T/NT比率。結閤早期胃癌中研究結果,GX1在胃腸道腫瘤早期時相探測方麵較肺癌具有更多優勢。
목적:분석종류혈관내피특이성파향태GX1재결장암여폐암중적현상차이,탐토GX1재위장도종류조기진치적응용개치。방법:구건하인결장암、폐암이식류라서모형,99 Tcm 직접법제비99 Tcm -GX1,경미정맥분별주입하인결장암、폐암소서체내,SPECT현상련속추종24h,관찰99 Tcm -GX1재결장암여폐암중현상차이,계산궤구화종류급심장감흥취구,비교량조T/NT비치차이。결과:99 Tcm 직접법표기GX1,소득표기솔재90%이상,무수순화,비활도대우200Ci/mmol,만족현상요구。결장암조하류소서자8h기우후지배측종류부위즉가견방사성농취,병고우심혈지본저,T/NT비치>1,18h현영최청석,수시간연장T/NT비치총체정체증추세;폐암조하류소서8h우후지배측종류부위무명현현영,자12h기종류부위개시출현방사성농취,병고우심혈지본저,18h현영최청석,T/NT비치수시간연장역정체증추세。비교량조T/NT비치,자8h지24h,결장암조비치지속고우폐암조。결론:GX1가파향도결장암여폐암하류소서적종류조직,병구유종류표지물적영상학특정,여폐암상비,GX1재결장암성상중구유경고적령민도、경고적체내종류조직체류솔화경고적T/NT비솔。결합조기위암중연구결과,GX1재위장도종류조기시상탐측방면교폐암구유경다우세。
Objective:To analyze the imaging variation of tumor vasculature homing PePtide GX1 in colon cancer and lung cancer. Methods:99 Tcm -GX1 was PrePared by labeling GX1 PePtide acquired by chemosynthesis with 99 Tcm O4 -using direct labeling method. ECT imaging of nude mice bearing tumor xenografts of human colon cancer and lung cancer injected with 99 Tcm -GX1 was Performed to analyze the imaging variation. T/NT ratios were calculat-ed by comParing the radioactivity in tumor and heart. Results:99 Tcm -GX1 was acquired with high label radiolabeling efficiency exceeding 90%,high sPecific activity beyond 200Ci/mmol,which confirmed the qualification of 99 Tcm -GX1 for ECT imaging. The tumor on the right flank can be visualized from 8h in colon cancer grouP with a increasing trend including higher radioactivity than heart and T/NT ratio greater than 1 on the whole. In lung cancer grouP,there was obvious radioactivity visualized in the tumor on the right flank from 12h comPared with the imaging at 8h and the increasing trend including higher radioactivity than heart and T/NT ratio greater than 1 was showed on the whole. The most clearly visualized imaging aPPeared at 18h in both grouPs. Continuous higher T/NT ratios between tumor and heart were observed in colon cancer grouP comPared to that of lung cancer grouP from 8h to 24h. Conclusion:GX1 owned the imaging feature of tumor marker by sPecific targeting to colon cancer and lung cancer tissue in tumor-bearing nude mice. ComPared with that of lung cancer,ECT imaging in colon cancer with GX1 PePtide showed higher sensitivity,tumor retention,and T/NT ratios. Combing the former results in gastric cancer,the suPeriority of GX1 PeP-tide for early detection in gastroenteric tumor was fully confirmed.